{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFigure 10 A to 10D provide for acetyl group GLP-1 (=\" G-2 \"\uff1bFigure 10 A), ethyl GLP-1 (=\" G-5 \"\uff1bFigure 10B), isobutyl group GLP-1 (=\" G-6 \"\uff1bFigure 10 C) and C- phenyl GLP-1 (=\" G-11 \"\uff1bFigure 10 D, nomenclature such as Fig. 6) it is anti- Reflect the series of drawing of stability detection (being cultivated with or without DPP4 overnight).\u201cON\u201d\uff1aCulture overnight.Corresponding EC50 values are shown as pM.\nFigure 12 is provided for unmodified GIP relative to CHCF<sub>3</sub>- GIP (compound I-4) stability detection (with or Do not cultivated with DPP4) result series of drawing.Unmodified peptide is degraded by DPP4, and I-4 is then to this ferment impedance.EC50 values are shown For pM.\nFigure 13 is provided for unmodified glycemic element relative to CHCF<sub>3</sub>The stability inspection of glycemic element (compound GCG-4) Survey and (cultivated with or without DPP4) result series of drawing.Unmodified peptide is degraded by DPP4, and GCG-4 is then to this ferment impedance. EC50 values are shown as pM.\nFigure 14 is provided for unmodified Ai Saiting (Exe) relative to CHCF<sub>3</sub>The peace of-Ai Saiting (compound EXE-4) Qualitative detection (cultivates) result series of drawing with or without DPP4.Unmodified peptide is degraded by DPP4, and Exe-4 is then to this ferment Complete impedance.EC50 values are shown as pM.\nFigure 15 is provided with CHCF<sub>3</sub>(\" F-TA \" in Fig. 6 or TA-4) N- terminals decoration co-activating has similar drug effect. EC50 values are shown as pM.\nFigure 18 offers compare GLP-1 (left column) relative to CHCF3-GLP-1 (right columns\uff1bG-4 in Fig. 6) it degrades for ferment Sensibility series of drawing.Not with ferment or with after DPP4, DPP9 or FAP culture overnight, by expression GLP-1 receptors Luciferin plum in cell detects and measures the activity of such peptide.Relative to unmodified GLP-1, G-4 derivatives are to inducing The ferment of drug effect loss has impedance (concentration not deviated to the right-response curve).\nFigure 19 provides natural GHRH (right column) relative to CHCF3-GHRH (\" C2-GHRH \", bottom column, the compound in Fig. 6 GH29-4) for the series of drawing of the sensibility of ferment degradation.It tests fresh stock solutions or cultivates (O/N) overnight with or without DPP4 Afterwards, the activity of such peptide is measured by the way that luciferin detects in the cell of expression GHRH receptors (GHRHR).Relative to GHRH, GH29-4 derivatives have impedance (concentration not deviated to the right-response curve) for the ferment for inducing drug effect loss."}
{"final_json": [{"molecule_name": "G-2", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "G-5", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "G-6", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "G-11", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "I-4", "protein_target_name": "DPP4", "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "GCG-4", "protein_target_name": "DPP4", "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "EXE-4", "protein_target_name": "DPP4", "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "TA-4", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "pM"}, {"molecule_name": "G-4", "protein_target_name": "GLP-1 receptors", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "GH29-4", "protein_target_name": "GHRHR", "binding_metric": null, "value": null, "unit": null}]}
